This summary is based on the fourth quarter fiscal 2007 earnings call conducted by FMC Corp. (FMC) on February 7, 2008.

Management:

- Investor Relations: Brennen Arndt
- Chairman, President, and CEO: William G. Walter
- VP and General Manager, Industrial Chemicals: Michael D. Wilson
- Sr. VP and CFO: Kim Foster

Key Investors Issues

- Sales were $674 million, up 15%.
- Earnings rose 235% to $40.9 million or 53 cents a share.
- The firm repurchased 560,000 shares at a cost of $30 million.

Full Year Highlights:

- Revenue was $2.6 billion, an increase of 12% from $2.3 billion in the prior year.
- Net income was $132.4 million, or $1.71 per share, as compared to $131.3 million, or $1.66 per diluted share, in the prior year.
- The firm repurchased 2.5 million shares at a cost of $110 million and cash dividends totaled $30 million.

Fourth Quarter Highlights

Sales were $674 million, up 15% from $587 million in the prior year due to sales gains across Asia and Latin America.

- Earnings were $40.9 million or 53 cents per share, up 235% from $12.2 million or 16 cents a share in 2006, on strong performance across all segments.
- The firm had no LIFO charge either income or expense, from a reported $15 million in LIFO income in 2006.
- Free cash flow was $150 million, and is expected to improve primarily due to higher profits, the reversal of one time inventory build in Ag to support Baltimore phase out, and the absence of SOLUTIA payment.
- The proceeds from the Princeton land sale are expected to be $60 million.
- The firm repurchased 560,000 shares at a cost of $30 million.

Performance of Business Lines:

- Ag products had earnings of almost $32 million up 44% versus a year ago, driven by higher sales in Asia and Latin America, and strong global supply chain performance.
- Sales of $229 million increased 18% as gains were realized in Asia and Latin America. - In Asia the sales increase was broad based driven robust cotton season in Pakistan and more favorable growing conditions in Indonesia, India, and Australia.
- In Latin America sales growth in Brazil was particularly strong, as the firm benefited from the buoyant agricultural economy, higher crop prices, and increased planted acres in key crops.

- Chemical earnings were $34 million, rising 39% versus the year ago quarter as a result of strong commercial performance in BioPolymer, higher volumes and selling prices for primary lithium compounds.
- Results were also impacted by continued manufacturing productivity improvements, offset in part by higher raw material cost.
- Revenue was $161 million, up 10% over the prior year''s quarter.

In BioPolymers strong commercial performance in the pharmaceutical and food ingredients markets and continued productivity improvements were only partially offset by higher specialty pulp prices.

- In pharmaceuticals, the firm benefited from the continued strong global demand for oral tablet drugs.
- Sales in India, China, and two generic drug manufacturers across all regions were particularly strong in the quarter.
- The food ingredient segment also performed well driven by volume growth in Asia and Latin America primarily in the dairy segment as well as a favorable product mix.
- In lithium earnings growth was a result of higher prices for primary lithium compounds and higher volumes in pricing and downstream specialty products.

- Industrial chemicals earnings of $29 million, were 36% higher than year ago, driven by higher selling prices in soda ash, volume growth across the segment and improved power market conditions in Spain.
- The segment is comprised of three businesses, alkali chemicals division or soda ash business, North American peroxygens which is comprised predominantly of hydrogen peroxide that also includes several specialty peroxygens.
- It also included Foret, the wholly owned Spanish subsidiary which manufactures peroxygens and phosphates.

Revenue was $285 million an increase of 15% from the prior year quarter driven by higher selling pricing in soda ash, volume growth across the segment, and favorable currency translation primarily the Euro.

- Overall, aggregate volume and net price benefits are expected to contribute $100 million to improved earnings for the segment in 2008.
- Raw material costs, energy, and price driven soda ash royalty payments in total are expected to be $50 million higher with phosphate rock prices at Foret being the primary driver.
- At the beginning of 2008, the North American soda ash industry remained in a sold out position with all U.S. producers operating at full capacity.
- Favorable supply demand conditions continue despite a flat U.S. market due to strong export demand growth in the absence of significant capacity additions.

The Granger Wyoming plant represents the lowest cost in most capitalization potential capacity in the industry.

- The facility is now running at an annual rate of 500,000 tones leaving the firm holding 800,000 tons of idle capacity at Granger and given the current export demand outlook, the firm has initiated steps to bring on the next increment capacity in 2009.
- In addition, the firm continues to structure longer term contracts to preserve the price and volume gains over the last few years, while providing for potential additional upside sight for 2009 and beyond.
- In the export markets Wyoming producers serve Asian and Latin American markets through ANSAC and in Asia ANSAC''s primary competition is the exporting Chinese producers and to a lesser degree Indian and African producers.